[Federal Register Volume 63, Number 42 (Wednesday, March 4, 1998)]
[Notices]
[Page 10643]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-5581]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Heart, Lung, and Blood Institute Special Emphasis Panel (SEP) 
meetings:

    Name of SEP: Role of Respiratory Infections in Childhood Asthma.
    Date: March 26, 1998.
    Time: 8:00 a.m.
    Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, 
Washington, DC 20007.
    Contact Person: Anne P. Clark, Ph.D., Two Rockledge Center, Room 
7186, 6701 Rockledge Drive, Bethesda, MD 20892-7924 (301) 435-0280.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of SEP: Psychosocial Factors and Cardiovascular Disease.
    Date: March 31, 1998.
    Time: 8:00 a.m.
    Place: Holiday Inn Bethesda, 8120 Wisconsin Avenue, Bethesda, 
Maryland 20814.
    Contact Person: C. James Scheirer, Ph.D., Two Rockledge Center, 
Room 7220, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-
0266.
    Purpose/Agenda: To review and evaluate grant applications.
    Name of SEP: Insulin Resistance Atherosclerosis Study (IRAS).
    Date: March 31-April 1, 1998.
    Time: 7:00 p.m.
    Place: Holiday Inn, 2 Montgomery Village Avenue, Gaithersburg, 
Maryland 20879.
    Contact Person: Anthony M. Coelho, Ph.D., Two Rockledge Center, 
Room 7194, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-
0288.
    Purpose/Agenda: To review and evaluate grant applications.
    These meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health.)

    Dated: February 25, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-5581 Filed 3-3-98; 8:45 am]
BILLING CODE 4140-01-M